Selected article for: "expression level and low level"
Author: Helal, Mohamed A.; Shouman, Shaimaa; Abdelwaly, Ahmad; Elmehrath, Ahmed O.; Essawy, Mohamed; Sayed, Shireen M.; Saleh, Amr H.; El-Badri, Nagwa
Title: Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia
  • Cord-id: 20l9xcmg
  • Document date: 2020_9_16
    • ID: 20l9xcmg
    Snippet: Lymphopenia is considered one of the most characteristic clinical features of the coronavirus disease 2019 (COVID-19). SARS-CoV-2 infects host cells via the interaction of its spike protein with the human angiotensin-converting enzyme 2 (hACE2) receptor. Since T lymphocytes display a very low expression level of hACE2, a novel receptor might be involved in the entry of SARS-CoV-2 into T cells. The transmembrane glycoprotein CD147 is highly expressed by activated T lymphocytes, and was recently p
    Document: Lymphopenia is considered one of the most characteristic clinical features of the coronavirus disease 2019 (COVID-19). SARS-CoV-2 infects host cells via the interaction of its spike protein with the human angiotensin-converting enzyme 2 (hACE2) receptor. Since T lymphocytes display a very low expression level of hACE2, a novel receptor might be involved in the entry of SARS-CoV-2 into T cells. The transmembrane glycoprotein CD147 is highly expressed by activated T lymphocytes, and was recently proposed as a probable route for SARS-CoV-2 invasion. To understand the molecular basis of the potential interaction of SARS-CoV-2 to CD147, we have investigated the binding of the viral spike protein to this receptor in-silico. The results showed that this binding is dominated by electrostatic interactions involving residues Arg403, Asn481, and the backbone of Gly502. The overall binding arrangement shows the CD147 C-terminal domain interacting with the spike external subdomain in the grove between the short antiparallel β strands, β1’ and β2’, and the small helix α1’. This proposed interaction was further confirmed using MD simulation and binding free energy calculation. These data contribute to a better understanding of the mechanism of infection of SARS-CoV-2 to T lymphocytes and could provide valuable insights for the rational design of adjuvant treatment for COVID-19. Communicated by Ramaswamy H. Sarma

    Search related documents:
    Co phrase search for related documents
    • acute sars cov respiratory syndrome coronavirus and low observe: 1, 2
    • acute sars cov respiratory syndrome coronavirus and lymphocyte activation: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and lymphocyte apoptosis: 1, 2
    • acute sars cov respiratory syndrome coronavirus and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute sars cov respiratory syndrome coronavirus and lymphocyte proliferation: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and lymphocytic count: 1, 2
    • acute sars cov respiratory syndrome coronavirus and lymphopenia cause: 1, 2, 3, 4
    • long range and lymphocyte count: 1, 2